Friday, September 19, 2014

Calithera Biosciences Sets IPO Pricing Range

South San Francisco-based biopharmaceuticals developer Calithera Biosciences has set its estimated IPO range, saying in a filing that it now expects to price at between $13.00 and $15.00 per share. The company is selling 6 million shares of its stock. Calithera is venture backed by Delphi Ventures, Morgenthaler Ventures, Advanced Technology Ventures, Adage Capital Partners, T. Rowe Price, Wellington Management, longwood Fund, and others. Calithera is working on cancer drugs.